FDA Inspection 1023275 — LifeCell Corporation

LifeCell Corporation — FEI 1000306051

The FDA completed an inspection of LifeCell Corporation on Aug 25, 2017 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 25, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Branchburg, NJ (United States)

Citations

IDCFRDescription
1472221 CFR 820.40Procedures not adequately established or maintained
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313021 CFR 820.100(a)Lack of or inadequate procedures
342621 CFR 820.50(a)(1)Documented evaluation
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.